Study: Failure to restart statins raises risks for cancer patients

04/4/2012 | MedPage Today (free registration)

University of Michigan researchers said head and neck cancer patients more than doubled their risk of death, heart attack, congestive heart failure, unstable angina or stroke if they failed to restart statin medications after surgery. They said reimbursement policies regarding restoration of these drugs are needed to ensure patients who need the medications have them when they leave the hospital.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations